|Bid||0.00 x 1200|
|Ask||106.59 x 800|
|Day's Range||106.29 - 107.54|
|52 Week Range||72.80 - 108.68|
|Beta (3Y Monthly)||0.24|
|PE Ratio (TTM)||25.30|
|Earnings Date||Jul 29, 2019 - Aug 2, 2019|
|Forward Dividend & Yield||2.98 (2.80%)|
|1y Target Est||106.19|
Procter & Gamble has expanded its offerings in the naturals category with the introduction of Tampax Pure organic tampons and Always Pure menstrual pads.
Tampax and Always, the leading period care brands from Procter & Gamble, introduce Tampax PURE, their new organic tampon option, and Always PURE pads – both free of dyes, fragrances, and chlorine bleaching that require no compromise on ingredients or protection. Tampax PURE tampons have a 100% organic cotton core and deliver the protection expected from Tampax every time. In speaking with thousands of tampon users in the last several years, it was clear that there was still a big unmet need in the natural menstrual category – an option that worked well,” said Amy Krajewski, Section Head Global Tampax Research & Development.
The well-known activist investor has reached a deal with Legg Mason Inc. that will net his fund three seats on the money manager's board of directors.
Procter & Gamble has completed the sale of 6.5 acres of its Gillette campus in South Boston, reportedly for $218 million.
PENJERLA/NEW DELHI, India (Reuters) - It was supposed to be Johnson & Johnson's biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad in southern India. Two sources familiar with J&J's operations in India and one state government official told Reuters production at the plant, at Penjerla in Telangana, never began because of a slowing in the growth in demand for the products.
PENJERLA/NEW DELHI, India May 19 (Reuters) - It was supposed to be Johnson & Johnson's biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad in southern India. Two sources familiar with J&J's operations in India and one state government official told Reuters production at the plant, at Penjerla in Telangana state, never began because of a slowing in the growth in demand for the products.
Retail sales, industrial production, and fixed asset investment all came in well short of estimates on a year-over-year basis. On Wednesday morning, the U.S. also reported some disappointing economic news. Retail sales, which were expected to rise 0.2% in the month of April, instead fell by 0.2%.
Nelson Peltz's firm, Trian Fund Management LP, is considering waging an activist fight to get Baltimore-based Legg Mason to improve its financial results, according to the Wall Street Journal.
The deal comes days after Boston-based General Electric Co. sold its headquarters campus for $252 million.
Thanks to another well-timed tweet by President Donald Trump, U.S. equities are bouncing back on Tuesday on fresh hope for a U.S.-China trade deal. Also helping was Trump's disputing of a New York Times report that the Pentagon is reviewing a military plan for Iran that involves sending 120,000 troops to the Middle East.This stands in stark contrast to the fears in play on Monday, with China vowing retaliatory measures including curtailing imports of Boeing (NYSE:BA) aircraft and the dumping of U.S. Treasury holdings. * 6 Trade War Stocks With a Lot of Risk The move was enough to push the Dow Jones Industrial Average back above its 200-day moving average and is focusing buyer attention on the handful of stocks that have largely ignored the month-long bout of volatility. Here are five worth a look:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Consumer Stocks :Procter & Gamble (PG)Procter & Gamble (NYSE:PG) shares have shaken off the broad market pressure to keep marching higher, inching towards a new record high as it keeps riding support near its 50-day moving average. Shares were also barely affected by the volatility seen late last summer as well, continuing an uptrend that started in April 2018 that has seen shares gain more than 50%.The company is scheduled to next report results on July 30 before the bell. Analysts are looking for earnings of $1.05 per share on revenues of $16.9 billion. When the company last reported on April 23, earnings of $1.06 per share beat estimates by two cents on a 1.1% rise in revenues. Coca-Cola (KO)Shares of Coca-Cola (NYSE:KO) are rising up to challenge resistance from double-top highs near the $50-a-share threshold. Zooming out, the stock has been in a steady if somewhat choppy uptrend since the 2009 bear market low -- the very definition of what you would expect from a well-run consumer staples company. * 7 Dividend Stocks to Buy as the Trade War Reignites Results will next be reported on July 25 before the bell. Analysts are looking for earnings of 62 cents per share on revenues of $9.4 billion. When the company last reported on April 23, earnings of 48 cents per share beat estimates by two cents on a 5.2% rise in revenues. Colgate-Palmolive (CL)Shares of Colgate-Palmolive (NYSE:CL) are pushing higher to challenge highs the stock last set in early 2018. This continues a sideways channel that has been in place since the middle of 2016. Shares were recently upgraded to "buy" by analysts at Zacks, who are looking for a $80-a-share price target.The company will next report results on July 26 before the bell. Analysts are looking for earnings of 72 cents per share on revenues of $3.9 billion. When the company last reported on April 26, earnings of 67 cents per share beat estimates by a penny on a 2.9% drop in revenues. Management reaffirmed its relatively bright 2019 outlook as well. General Mills (GIS)General Mills (NYSE:GIS) shares are continuing to attempt a breakout up and over three-month resistance near the $52-a-share level, setting up a run at its early 2018 highs near the $57-a-share level. Such a move would be worth a gain of nearly 10% from here. Shares have been trading at a discount to the average consumer packaged goods stock this year, making its relative price stability even more valuable in these volatile times. * 7 Cloud Stocks to Buy on Overcast Days The company is scheduled to next report results on June 26 before the bell. Analysts are looking for earnings of 76 cents per share on revenues of $4.3 billion. When the company last reported on March 20, earnings of 83 cents per share beat estimates by 14 cents on an 8.1% rise in revenues. GoPro (GPRO)GoPro (NASDAQ:GPRO) is something of an unusual pick for this list, on account of its position as a turnaround consumer electronics name. Shares have cratered since reaching a high in late 2015, losing some 95% of their value into the low set in December. Since then, shares have been scrambling higher and are pushing up and over their April high today.The company will next report results on August 1 after the close. Analysts are looking for earnings of four cents per share on revenues of $301 million. When the company last reported on May 9, a loss of seven cents per share beat estimates by two cents on a 20.1% rise in revenues.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 6 Trade War Stocks With a Lot of Risk * 7 Bond ETFs to Buy * 10 Stocks That Could Squeeze Short Sellers, Including CGC Compare Brokers The post 5 Consumer Stocks Ready to Push Higher appeared first on InvestorPlace.
French retailer Carrefour and U.S. waste recycling company TerraCycle launched on Tuesday the test for their 'Loop' initiative which they hope will tackle the problems of plastic waste threatening to destroy the environment. The 'Loop' online platform will allow shoppers in the Paris area to buy orange juice, powder detergent or shampoo in reusable containers that do not result in waste. Users put down a refundable deposit via the Loop website when ordering products, which are delivered in reusable glass and metal bottles, and shipped in a tote bag to shoppers' doors.
How quickly people think of recession and tariffs. Campbell's , Procter , Kimberly , Clorox get the money immediately. It's really insane of course because PG and KMB are so dependent upon China for growth but idiot money is at work and idiot money has a lot of money and ETFs to boot.
DEEP DIVE (This story has been updated with closing stock market prices.) Following a week of losses, investors were faced Monday with a heavy sell-off of U.S. stocks. Following President Trump’s decision to increase tariffs to 25% from 10% on $200 billion in annual imports from China, which went into effect Friday, China said it would set 25% tariffs on $60 billion in annual imports from the U.
Greater Cincinnati stocks plunged along with the stock market Monday amid the escalating trade battle between the U.S. and China.
Strong brands are driving growth in Coty's (COTY) Luxury unit. Further, the company gains from prudent efforts to boost efficiency.
Since late March, Aurora Cannabis (NYSE:ACB) stock has been in a fairly tight trading range. But next Tuesday we may see some action. Yes, the company will report its fiscal third quarter results. No doubt, it will be a critical, as investors will want to get a sense of how the Canadian recreational market is tracking, and after the Cronos Group (NASDAQ:CRON) letdown, there might be some concern about Aurora stock.Source: Shutterstock Now as for the prior quarter for Aurora stock, the company handily beat its own estimates. Revenues hit $40.7 million for the quarter, up a sizzling 83% on a quarter-over-quarter basis. Note that the company had put out a forecast of $37.6 million.Although, the losses were hefty, coming to $178.6 million. A big reason for this has been the aggressive M&A strategy, which means that the company has to make adjustments for mark-to-mark accounting. Consider that there have been 15 deals since the summer of 2016.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Dangerous Dividend Stocks to Stay Far Away From A Closer Look at Aurora StockSo what about the expectation for Aurora stock for Q3? Well, as should be no surprise, the growth is likely to continue at a robust pace. The consensus is for revenues to come to $55.3 million and the loss be 4 cents a share. But given that the cannabis opportunity in Canada is in the nascent stages, the forecast is likely to be more of an educated guess.There were certainly other notable highlights during the quarter. Here's a look: * The company signed a binding agreement to acquire Chemi Pharmaceutical, which is a privately-held Ontario lab that focuses on analytics for the pharma and cannabis industries. A key asset is the Health Canada Drug Establishment Licence that allows for performing certified GMP compliant quality control testing. The company will be merged into Aurora's Anandia Laboratories subsidiary. * Aurora announced it has purchased the remaining shares of Hemco, which is a top provider of hemp-based foods, fiber and nutraceuticals. The company is also commissioning its 56,000 square foot hemp processing facility for the extraction of CBD. * The company completed its acquisition of Whistler Medical Marijuana Corporation, which is one of the top premium cannabis brands in Canada. The deal should allow for expansion in both medical and consumer markets. Consider that the production capacity is expandable to over 15,000 kg. * Aurora received approval to sell cannabis oils to German pharmacies. In fact, the company is already the market leader in the country. Bottom Line on ACB StockWhen it comes to ACB stock, there are both short-term and long-term tailwinds. No doubt, right now much of the growth will come from the Canadian market. The good news is that the company has been able to effectively scale its operations. Production is expected to go from 150,000 kg per year to more than 500,000 kg per year by mid-2020.As for the long-term catalysts for ACB stock, there is the medical business. The company has about 40 clinical trials and has also built a strong distribution footprint in Europe and Latin America. Just a small number of new therapeutics can have a big impact on the top-line.But there is another key factor for ACB stock: The company has appointed Nelson Peltz as a Strategic Advisor. He is the CEO and founding partner of the Trian Fund, which is a top investment firm that's focused on the consumer products sector. It has stakes in companies such as Procter & Gamble (NYSE:PG) and Mondelez International (NASDAQ:MDLZ).In other words, Nelson will likely be critical in helping ACB find major strategic partners to help propel the growth, similar to what other cannabis firms like Canopy Growth (NYSE:CGC) and Cronos have done. So yes, on the earnings call, it's a good bet that analysts will want to hear how things are progressing on this front.Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dangerous Dividend Stocks to Stay Far Away From * 7 Tips for New Investors Young and Old * 10 Great Stocks to Buy on Dips Compare Brokers The post It Makes Sense to Lay off Aurora Stock Ahead of Next Week's Earnings appeared first on InvestorPlace.
Cramer says that one of his favorite ways of picking winning stocks is to wait for a truly ugly session, a real bruiser and see what's still hanging in there.
"When a sell-off goes into its third day, the buyers just stand there and absorb the market's body blows. And then stocks start rallying like nobody's business," Jim Cramer says.